Cereno Scientific utvecklar ett nytt förebyggande läkemedel mot blodpropp som bygger på kroppens egen intelligenta propplösningsmekanism som ska användas vid behandling av trombosrelaterade kardiovaskulära sjukdomar på den globala marknaden. Hjärt- och kärlsjukdomar är idag den vanligaste dödsorsaken i världen.

Quotes for Cereno Scientific AB

Right Now

+/-
-0,20
%
-3,28%
Latest
5,90
High
6,00
Low
5,56
Volume
159 863
Turnover (SEK)
932 894
Value (MSEK)
66,0

Board

CEO

  • Sten R Sörensen

Chairman Of The Board

  • Catharina Bäärnhielm

Board

  • Catharina Bäärnhielm
  • Björn Dahlöf
  • Jonas Fajerson Säljö
  • Sverker Jern
  • Gunnar Olsson
  • Klementina Österberg

Videos

Largest Owner

Name Capital % Votes % Date
Sverker Jern 10,59 18,63 2018-06-30
Niklas Bergh 10,47 18,42 2018-06-30
GU Ventures 9,14 5,74 2018-06-30
Pia Larsson 5,53 3,47 2018-06-30
Galenica AB 5,10 3,20 2018-06-30
Bridge Consulting AB 3,89 2,44 2018-06-30
Avanza Pension 2,77 1,74 2018-06-30
Jonas Säljö 2,50 8,54 2018-06-30
Björn Dahlöf 2,26 7,79 2018-06-30
Göran Ofsén 2,18 1,37 2018-06-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Key Numbers

  3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Number of months that the report spans Q1 3 Months Q4 3 Months Q3 3 Months Q2 3 Months Q1 3 Months Q4 3 Months Q3 3 Months
Total revenue 1.31 1.98 3.80 2.18 0.00 0.00 0.00
Earnings before interest and tax -1.81 -1.56 -1.20 -1.11 -0.74 -1.00 -1.10
Profit before tax -1.81 -1.56 -1.20 -1.12 -0.74 -1.00 -1.10
Net profit -1.81 -1.56 -1.20 -1.12 -0.74 -1.00 -1.10
Earnings per share -0.16 -0.14 -0.11 -0.1 -0.07 -0.09 -0.1
Dividend per share
Equity 21.73 23.53 25.09 26.31 27.43 28.17
Fixed assets 18.04 16.71 14.75 10.44 7.64 5.87
Intangible assets
Current assets 6.40 9.05 13.11 18.20 21.98 24.60
Total asset 24.44 25.76 27.85 28.64 29.62 30.47
Long term liabilities 0.40 0.40 0.40 0.40 0.40 0.40
Current liabilities 2.32 1.83 2.36 1.93 1.79 1.90
Number of shares (st) 10 990 500 10 990 500 10 990 500 10 990 500 10 990 500 10 990 500 10 990 500

Upcoming reports

  • 2019-02-22 Year End Report

  • 2018-11-15 Interim Report Q3

  • 2018-08-30 Half Year Report